FDA Clears NeuroStar for Adolescent Depression – A Brighter Future for Teen Mental Health?
FDA Clears NeuroStar for Adolescent Depression – A Brighter Future for Teen Mental Health? Neuronetics‘ NeuroStar recently received FDA approval as an add-on therapy for adolescents aged 15 to 21 suffering from major depressive disorder (MDD). This groundbreaking approval represents a significant advance in the treatment of young people’s mental health. Depression in adolescents is […]